Study of a Pandemic Influenza Vaccine
NCT00136331
·
clinicaltrials.gov ↗
PHASE1
Phase
COMPLETED
Status
400
Enrollment
INDUSTRY
Sponsor class
Conditions
Influenza
Interventions
BIOLOGICAL:
Pandemic influenza vaccine
Sponsor
Seqirus